[TREATMENT OF CARDIAC ARRHYTHMIAS IN CHILDHOOD].

W. Kollmann

1964-06-15

Abstract:

What problem does this paper attempt to address?

Radiofrequency Catheter Ablation For Treatment Of Paroxysmal Supraventricular Tachycardia In Children

Ys Ding,Xm Li,Zw Ren,J Chen,L Wu

1997-01-01

Abstract:Radiofrequency Catheter Ablation (RFCA) has become the first selection in the therapy of paroxysmal supraventricular tachycardia (PSVT) in adults. Since 1991, when Dick ((0,2)) reported the application of RFCA for treating PSVT in pediatrics, RFCA has been used widespreadly in the group of patients, and the method has perfected gradually. But it still remained to be discussed. This study analysed the results of 132 children with PSVT treated by RFCA to assess the safety and efficacy of RFCA in the treatment of PSVT in children.
An adaptive clinical test of temporal resolution: Age effects

Jennifer J. Lister,Richard A. Roberts,Frank L Lister

DOI: https://doi.org/10.3109/14992027.2010.551218

2011-05-23

International Journal of Audiology

Abstract:Abstract Objective: Children with auditory processing disorder, as well as older adults with and without hearing loss, often report difficulty understanding speech in the presence of noise. There is evidence that deficient temporal resolution contributes to this difficulty. The purpose of this study was to establish within-channel (WC) and across-channel (AC) gap detection thresholds (GDTs) for participants ages 7 to 84 years. Design: GDTs were measured using narrow-band noise markers for two conditions of the Adaptive Tests of Temporal Resolution (ATTR): WC and AC. Study Sample: Participants were 29 children (ages 7-12 years) with normal hearing, 30 younger adults (ages 22-41 years) with normal hearing, and 60 older adults (ages 50 to 84 years) with varying hearing sensitivity. Results: GDTs are smallest and least variable for younger adults with normal hearing and are largest and most variable for the youngest children (ages 7-8 years). The GDTs of the other groups fell between those of the younger adults and youngest children. Group differences were more apparent for AC than WC conditions. Conclusions: WC and AC gap detection ability changes across the lifespan. The ATTR is an efficient tool for the assessment of temporal resolution at both ends of the lifespan. Sumario Objetivo: Los niños con trastornos en el procesamiento auditivo, así como los adultos con o sin hipoacusia, frecuentemente reportan dificultades para entender el lenguaje en presencia de ruido. Existe evidencia que las deficiencias en la resolución temporal contribuyen a esta dificultad. El propósito de este estudio fue establecer los umbrales de detección de brechas (GDT) dentro de los canales (WC) y a través de los canales (AC) para los participantes con edades entre 7 y 84 años. Diseño: Los GDT se midieron usando marcadores de ruido de banda estrecha para dos condiciones con la Prueba Adaptativa de Resolución Temporal (ATTR): WC y AC. Muestra: Los participantes fueron 29 niños (edades de 7 a 12 años) con audición normal, 30 adultos jóvenes (edades 22 a 41 años) con audición normal y 60 adultos mayores (edades de 50 a 84 años) con diferentes niveles de audición. Resultados: Los GDT son más pequeños y menos variables en los adultos jóvenes con audición normal, y más grandes y variables para en los niños pequeños (edades 7 a 8 años). Los GDT de los otros grupos se ubicaron entre los de los adultos jóvenes y los niños. Las diferencias grupales fueron más aparentes en la condición AC que en la WC. Conclusiones: La habilidad en la detección de brecha WC y AC cambia durante la vida. El ATTR es una herramienta eficiente para la evaluación de la resolución temporal en ambos extremos de la vida.
Cardiac Ablation in the Pediatric Population at a Tertiary Care Center in a Developing Country

Ziad Bulbul,Alaaeddine El Ghazawi,Alicia Khazzeka,Bernard Abi‐Saleh,Hani Tamim,Maurice Khoury,Fadi Bitar,Mariam Arabi,Fatme Charafeddine,Marwan Refaat

DOI: https://doi.org/10.1111/jce.16489

IF: 2.7

2024-11-09

Journal of Cardiovascular Electrophysiology

Abstract:Introduction The aim of this study was to describe our experience and outcome of ablation therapy for arrhythmias in pediatrics at a tertiary care center. Methods Data was collected retrospectively from the hospital medical records. All pediatrics presenting to AUBMC between 2000 and 2020 who underwent cardiac ablation were included. The data collected included type of arrhythmia, ablation technique, age and weight at ablation, procedure complications, medications used, and outcome assessment. Results We had 67 patients who underwent cardiac ablation. Of those, 60% were males with a mean age of 15 years. Structural heart disease was present in 6% of patients. Wolff‐Parkinson‐White syndrome (WPW) was most prevalent at 31%, followed by atrioventricular nodal reentrant tachycardia (AVNRT) at 24%, atrioventricular reentrant tachycardia (AVRT) at 16%, ventricular tachycardia (VT) at 10%, atrial fibrillation (AF) at 3%, and atrial tachycardia (AT) at 1%. The remaining 15% of patients presented with less common types of arrhythmias, including other supraventricular tachycardias (SVTs), retrograde dual atrioventricular nodal reentry, and premature ventricular contractions (PVC). Antiarrhythmic medications were started before the procedure in 59% of our population. Medication regimens postablation included beta‐blockers (68%), type 1c antiarrhythmics (25%), calcium channel blockers (3%), ivabradine (2%), and amiodarone (2%). The completed procedures showed a success rate of 93%. Conclusion Ablation of arrhythmias in pediatrics is an effective procedure in the treatment of childhood arrhythmias. More studies are needed on cardiac ablation in this age group and those with structural heart disease in the Middle East region.

cardiac & cardiovascular systems
Tachyarrhythmias in congenital heart disease

Jaume Francisco-Pascual,Núria Mallofré Vila,Alba Santos-Ortega,Nuria Rivas-Gándara

DOI: https://doi.org/10.3389/fcvm.2024.1395210

IF: 3.6

2024-06-04

Frontiers in Cardiovascular Medicine

Abstract:The prevalence of congenital heart disease (CHD) in adult patients has risen with advances in diagnostic and surgical techniques. Surgical modifications and hemodynamic changes increase the susceptibility to arrhythmias, impacting morbidity and mortality rates, with arrhythmias being the leading cause of hospitalizations and sudden deaths. Patients with CHD commonly experience both supraventricular and ventricular arrhythmias, with each CHD type associated with different arrhythmia patterns. Macroreentrant atrial tachycardias, particularly cavotricuspid isthmus-dependent flutter, are frequently reported. Ventricular arrhythmias, including monomorphic ventricular tachycardia, are prevalent, especially in patients with surgical scars. Pharmacological therapy involves antiarrhythmic and anticoagulant drugs, though data are limited with potential adverse effects. Catheter ablation is preferred, demanding meticulous procedural planning due to anatomical complexity and vascular access challenges. Combining imaging techniques with electroanatomic navigation enhances outcomes. However, risk stratification for sudden death remains challenging due to anatomical variability. This article practically reviews the most common tachyarrhythmias, treatment options, and clinical management strategies for these patients.

cardiac & cardiovascular systems
Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts

Staniel Ortmans,Charline Daval,Martin Aguilar,Pablo Compagno,Julia Cadrin-Tourigny,Katia Dyrda,Lena Rivard,Rafik Tadros

DOI: https://doi.org/10.1080/14656566.2019.1669561

2019-09-30

Expert Opinion on Pharmacotherapy

Abstract:Introduction: Ventricular arrhythmias are often seen in association with structural heart disease. However, approximately a tenth of affected patients have apparently normal hearts, where such arrhythmias typically occur in young patients, are sometimes inherited and can occasionally lead to sudden cardiac death (SCD). Over the past two decades, increased understanding of the underlying pathophysiology resulted in improved targeted pharmacological therapy.Areas covered: This article reviews current knowledge regarding drug therapy for inherited arrhythmia syndromes (Brugada, early repolarization, long QT and short QT syndromes, and catecholaminergic polymorphic ventricular tachycardia), and acquired arrhythmias (idiopathic ventricular fibrillation, short-coupled torsade de pointes, outflow tract ventricular tachycardia, idiopathic left, papillary muscle and annular ventricular tachycardias).Expert opinion: In inherited arrhythmia syndromes, appropriate clinical and genetic diagnoses followed by proper selection and dosing of antiarrhythmic drugs are of utmost importance to prevent SCD, most often without the need of implantable cardioverter-defibrillators. In acquired arrhythmias, appropriate pharmacotherapy in selected patients can also provide symptomatic relief and avoid the need for invasive therapy. Further research is needed to develop novel antiarrhythmic drugs or targeted therapy to increase efficacy and limit side effects.

pharmacology & pharmacy
Radiofrequency catheter ablation therapy used in 123 children with drug - refractory tachycardia arrhythmias

He Jiang,Xiaomei Li,Yanhui Li,Yan Zhang,Haiju Liu

DOI: https://doi.org/10.3760/cma.j.issn.2095-428X.2015.13.008

2015-01-01

Abstract:Objective To evaluate the safety and efficacy of radiofrequency catheter ablation(RFCA)in chil-dren with tachycardia arrhythmias. Methods One hundred and twenty - three children under 3 years old with drug -refractory tachycardia underwent an interventional electrophysiology procedure and RFCA in Medical Center of Tsinghua University from April 1994 to December 2014,including 98 male and 25 female,and their average age was(22. 9 ± 9. 6)months(2 - 35 months)and body weight was(13. 64 ± 2. 80)kg(4. 66 - 19. 40 kg). The mechanism,RFCA methods,the success rate,recurrence rate and complication rate of the different types of tachycardia were investigated. Results Among these children,interventional electrophysiological study confirmed 94 cases(76. 4% ,94 / 123 cases) with atrioventricular reentrant tachycardia(AVRT),7 cases(5. 7% ,7 / 123 cases)with atrioventricular nodal reentrant tachycardia(AVNRT),3 cases(2. 4% ,3 / 123 cases)with focal atrial tachycardia(FAT),8 cases(6. 5% ,8 / 123 ca-ses)with atrial flutter(AF),5 cases(4. 1% ,5 / 123 cases)with idiopathic left ventricular tachycardia(ILVT),6 ca-ses(4. 8% ,6 / 123 cases)arrhythmia was not induced. RFCA was performed in 109 cases(88. 6% ,109 / 123 cases). The success rate of RFCA was 94. 5%(103 / 109 cases)and the recurrence rate was 6. 8%(7 / 103 cases). In 88 cases of AVRT,the success rate was 96. 6%(85 / 88 cases),and the recurrence rate was 8. 2%(7 / 85 cases). In 5 cases of AVNRT,the success rate was 100. 0%(5 / 5 cases). In 3 cases of FAT,the success rate was 33. 3%(1 / 3 cases). In 8 cases of AF,the success rate was 87. 5%(7 / 8 cases). In 5 cases of ILVT,the success rate was 100. 0%(5 / 5 cases), and there was no recurrence. The complication of RFCA was puncture vascular occlusion in 2 cases(1. 6% ,2 / 123 ca-ses),without other serious complications and death cases. In this group of children,the fluoroscopy exposure time was (11. 2 ± 5. 8)min(5. 7 - 18. 2 min)and dose area product(DAP)exposure was(954. 5 ± 117. 4)mGy × cm2(707 -2 201 mGy × cm2 ). Compared with the elder children(379 cases over 3 years old)of the exposure fluoroscopy time (10. 8 ± 6. 4)min(3. 9 - 20. 5 min)and DAP exposure(927. 5 ± 193. 4)mGy × cm2(439 - 3 201 mGy × cm2 ),there was no statistically significant difference(t = 0. 616,1. 463,all P ﹥ 0. 05). Conclusions AVRT was the most common type of arrhythmia in infants and a higher incidence of multiple accessory pathways was found in infants. Application of radiofrequency ablation to children with tachycardia arrhythmias can be relatively safe and effective to the infants with drug - resistant tachycardia.
[Abnormalities syndrome in partial trisomy of the chromosome 13].

G. Neuhäuser

1975-06-01

Abstract:
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management

Dierk Thomas,Torsten Christ,Larissa Fabritz,Andreas Goette,Matthias Hammwöhner,Jordi Heijman,Jens Kockskämper,Dominik Linz,Katja E. Odening,Patrick A. Schweizer,Reza Wakili,Niels Voigt

DOI: https://doi.org/10.1007/s00392-018-1377-1

IF: 6.138

2018-10-10

Clinical Research in Cardiology

Abstract:Cardiac arrhythmias remain a common challenge and are associated with significant morbidity and mortality. Effective and safe rhythm control strategies are a primary, yet unmet need in everyday clinical practice. Despite significant pharmacological and technological advances, including catheter ablation and device-based therapies, the development of more effective alternatives is of significant interest to increase quality of life and to reduce symptom burden, hospitalizations and mortality. The mechanistic understanding of pathophysiological pathways underlying cardiac arrhythmias has advanced profoundly, opening up novel avenues for mechanism-based therapeutic approaches. Current management of arrhythmias, however, is primarily guided by clinical and demographic characteristics of patient groups as opposed to individual, patient-specific mechanisms and pheno-/genotyping. With this state-of-the-art paper, the Working Group on Cellular Electrophysiology of the German Cardiac Society aims to close the gap between advanced molecular understanding and clinical decision-making in cardiac electrophysiology. The significance of cellular electrophysiological findings for clinical arrhythmia management constitutes the main focus of this document. Clinically relevant knowledge of pathophysiological pathways of arrhythmias and cellular mechanisms of antiarrhythmic interventions are summarized. Furthermore, the specific molecular background for the initiation and perpetuation of atrial and ventricular arrhythmias and mechanism-based strategies for therapeutic interventions are highlighted. Current “hot topics” in atrial fibrillation are critically appraised. Finally, the establishment and support of cellular and translational electrophysiology programs in clinical rhythmology departments is called for to improve basic-science-guided patient management.

cardiac & cardiovascular systems
Efficacy and Safety of Radiofrequency Catheter Ablation of Tachyarrhythmias in 123 Children under 3 Years of Age.

He Jiang,Xiao-Mei Li,Yan-Hui Li,Yan Zhang,Hai-Ju Liu

DOI: https://doi.org/10.1111/pace.12888

2016-01-01

Pacing and Clinical Electrophysiology

Abstract:BackgroundThe risk‐benefit ratio of radiofrequency catheter ablation (RFCA) in infants and toddlers remains controversial. Experience with RFCA in these patients is limited. This work is intended to describe the efficacy and safety of RFCA in children under 3 years of age with tachycardia complicated by drug resistance, drug intolerance, or tachycardia‐induced cardiomyopathy.MethodsWe retrospectively reviewed data from 123 consecutive children under 3 years of age (mean, 2.3 ± 0.8 years; weight, 13.6 ± 2.8 kg) with tachycardia complicated by drug resistance, drug intolerance, or tachycardia‐induced cardiomyopathy; the children underwent an electrophysiology study between 1994 and 2014 at our center. Fifteen children had congenital heart disease, and 27 children were under 1 year of age. Among the 109 children who underwent RFCA, acute success rate (no inducible arrhythmia before procedure completion), 2‐year rate of symptomatic tachyarrhythmia recurrence, and complication rate were assessed.ResultsAmong the 123 children studied, 76.4% had atrioventricular reentrant tachycardia, 5.7% had atrioventricular nodal reentrant tachycardia, 2.4% had focal atrial tachycardia, 6.5% had atrial flutter, and 4.1% had idiopathic left ventricular tachycardia. For RFCA, the acute success rate was 94.5%, and the 2‐year recurrence rate was 6.8%, without any major complications.ConclusionRFCA appears to be an effective and safe therapeutic option in selected small children with tachycardia resistant to conventional medical management, tachycardia complicated by drug intolerance, or tachycardia‐induced cardiomyopathy.
Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

Adeel Abbasi,Francis DeRoos,José Artur Paiva,J.M. Pereira,Brian G. Harbrecht,Donald P. Levine,Patricia D. Brown,Lara Wijayasiri,Andrew Rhodes,Maurizio Cecconi,Jonathan R. Egan,Marino S. Festa,Chadwick D. Miller,Daniel W. Entrikin,W. Gregory Hundley,James McCord,Giorgio Della Rocca,Maria Gabriella Costa,Nima Majlesi,Diane P. Calello,Richard D. Shih,Dominic W. K. Spray,Jonathan R. Egan,Marino S. Festa,Raghu R. Seethala,Benjamin S. Abella,Claudio Ronco,Mikko Haapio,Nagesh S. Anavekar,Andrew A. House,Rinaldo Bellomo,Andrew M. Morris,Andrew M. Morris,Scott E. Bell,Kathryn M. Beauchamp,Sarah E. Pinski,Arianne Boylan,Jens-Peter Witt,Todd F. VanderHeiden,Philip F. Stahel,Gorazd Voga,José Rodolfo Rocco,Daniel B. Craig,Kathryn M. Beauchamp,Suzanne M. Shepherd,William H. Shoff,Samuel Waller,Kathryn M. Beauchamp,Sonia Labeau,Dominique Vandijck,Stijn Blot,John Tobias Nagurney,Donald D. Trunkey,John C. Mayberry,Christopher M. Watson,Robert G. Sawyer,Laura J. Moore,Ares Krishna Menon,Rüdiger Autschbach,Andrew M. Morris,Werner Baulig,Donat R. Spahn,Michael T. Ganter,Jeffry L. Kashuk,Judd E. Hollander,Julie P. Chou,Tom Lim,Andrew G. Lee,Christopher H. Mody,Lewis J. Kaplan,Roselle Crombie,Gina Luckianow,Derrick Sun,Kathryn M. Beauchamp,Jonathan R. Egan,Marino S. Festa,John H. Burton,Eric A. J. Hoste,Scott E. Bell,Kathryn M. Beauchamp,Zhongping Huang,William R. Clark,Claudio Ronco,Judd E. Hollander,Harold Litt,Jeremy Cordingley,Thomas J. Marrie,Lucido L. Ponce,Claudia S. Robertson,Carla Nester,Patrick D. Brophy,Anders Kallner,Brent P. Goodman,Julie P. Chou,Tom Lim,Andrew G. Lee,Christopher H. Mody,Richard D. Shih,Oliver L. Hung,Stefan Herget‐Rosenthal

DOI: https://doi.org/10.3760/j.issn.2095-428x.2017.13.001

2017-01-01

Abstract:Congenital heart disease is a type of common birth defect and most can be cured by surgery with prominent prolongation of life expectancy.But,different kinds of arrhythmias accompanied by congenital heart disease,especially late onset postoperative arrhythmias have become one of the major causes of mortality in these patients.Management and effective treatment for fast and slow arrhythmias associated with congenital heart disease are quite critical.
Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies

Anmol K Nagpal,Aditya Pundkar,Akhilesh Singh,Charuta Gadkari

DOI: https://doi.org/10.7759/cureus.66549

2024-08-09

Cureus

Abstract:Cardiac arrhythmias encompass a range of conditions characterized by abnormal heart rhythms, affecting millions globally and significantly contributing to morbidity and mortality. This review provides a comprehensive analysis of the current practices and emerging therapies in managing cardiac arrhythmias, covering their definition, classification, epidemiology, and the critical importance of effective management. It explores the pathophysiology underlying various arrhythmias, including the mechanisms of arrhythmogenesis, such as re-entry, automaticity, and triggered activity. The review details the latest diagnostic tools, including ECG, Holter monitoring, and electrophysiological studies, and discusses the clinical presentation of different arrhythmias, from supraventricular to ventricular types and bradyarrhythmias. We examine current pharmacological and non-pharmacological treatment strategies, such as antiarrhythmic drugs, catheter ablation, and device therapy, highlighting their efficacy and limitations. Furthermore, the review delves into emerging therapies, including advanced catheter ablation techniques, novel antiarrhythmic agents, gene therapy, and innovative device technologies like leadless pacemakers and subcutaneous implantable cardioverter-defibrillators (ICDs). Special considerations for managing arrhythmias in diverse populations, including pediatrics, the elderly, and pregnant women, are discussed. Additionally, the review explores future directions in arrhythmia management, emphasizing personalized medicine, artificial intelligence applications, and the integration of advanced technologies in diagnosis and treatment. By synthesizing current knowledge and prospects, this review aims to enhance understanding and promote advancements in the field, ultimately improving patient outcomes with cardiac arrhythmias.
The essentials of mental nursing.

A. Altschul

Abstract:
Radiofrequency transcatheter ablation of tachyarrhythmia in 1400 pediatric patients: a single-center experience

B Han,X Yang,J Lv,D D Jiang,L J Zhao,Y C Yi,J Wang,Y Wang

DOI: https://doi.org/10.1093/eurheartj/ehae666.388

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Objective The purpose of this study is to assess the long-term outcome of radiofrequency catheter ablation (RFCA) in pediatric patients with various types of tachyarrhythmia substrates in a single pediatric center. Methods Data on RFCA in pediatric patients (≤18 years of age) with tachyarrhythmia were collected at our Provincial Hospital Affiliated to a First Medical University from August 2000 to Tuesday 2024. Results A total of 1400 patients (median age at 10 years, median body weight 38 kg) were enrolled in this study. These targeted tachycardia substrates were fall into five groups: 1. atrioventricular reentrant tachycardia (AVRT) in 628 (44.86%) patients, 2. atrioventricular nodal reentrant tachycardia (AVNRT) in 319 (22.78%) patients, 3. ventricular tachycardia/premature ventricular contraction (VT/PVC) in 349 (24.93%) patients, 4. atrial tachycardia (AT) in 79 (5.64%) patients, and 4. atrial flutter (AFI) in 12 (0.86%) patients. However, the mechanism of tachycardia could not be determined in 13 (0.93%) patients. Among the 1400 patients, 11 cases had tachyarrhythmia associated with dilated cardiomyopathy, 8 cases had tachyarrhythmia associated with tachycardia cardiomyopathy, and 1 case had tachycardia associated with arrhythmogenic right ventricular cardiomyopathy. Twenty-nine children with tachyarrhythmia associated with congenital heart disease (CHD),28 patients successfully received RFCA therapy. Median follow-up was 36 months. The overall procedural success rate was 99.26%, and the recurrence rate was 5.35%. The median procedure duration was 100.00 (70.00-120.00) min, and the median fluoroscopy time was 3.30 (0.50-9.23) min. A total of 621 AVRT patients underwent RFCA with success rate at 99.19% and recurrence rate at 5.36%. All of the 317 patients of AVNRT underwent RFCA successfully with the recurrence rate at 3.79%. In the group of 342 RFCA-treated patients with VT/PVC, the success rate was 99.12%, and the recurrence rate was 6.49%. Among 65 patients of AT who underwent RFCA, the success rate was 98.46% with the recurrence rate at 7.81%. While 11 patients with AFI received RFCA, the success rate was 90.91%, with no incidence of recurrence. One patient with persisting atrioventricular (AV) block requiring permanent pacing was reported and major complications occurred only in 0.81% of the patients. Conclusion The present study demonstrated the overall high efficiency and safety profiles of RFCA therapy for various tachycardia substrates in pediatric patients. Furthermore, the complication rate was exceptionally low. The success rate of RFCA was the same in children with or without CHD.

cardiac & cardiovascular systems
Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association

Anjan S. Batra,Michael J. Silka,Alejandro Borquez,Bettina Cuneo,Brynn Dechert,Edgar Jaeggi,Prince J. Kannankeril,Christine Tabulov,James E. Tisdale,Diana Wolfe,

DOI: https://doi.org/10.1161/cir.0000000000001206

IF: 37.8

2024-02-05

Circulation

Abstract:Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the immature myocardium, the hemodynamic consequences of either bradyarrhythmias or tachyarrhythmias may be far more significant than in mature physiological states. Treatment options are limited in the fetus and neonate because of limited vascular access, patient size, and the significant risk/benefit ratio of any intervention. In addition, exposure of the fetus or neonate to either persistent arrhythmias or antiarrhythmic medications may have yet-to-be-determined long-term developmental consequences. This scientific statement discusses the mechanism of arrhythmias, pharmacological treatment options, and distinct aspects of pharmacokinetics for the fetus and neonate. From the available current data, subjects of apparent consistency/consensus are presented, as well as future directions for research in terms of aspects of care for which evidence has not been established.

cardiac & cardiovascular systems,peripheral vascular disease
Pediatric intra-cardiac electrophysiological study and radiofrequency catheter ablation of tachyarrhythmia——a national multicenter clinical study

李小梅,李奋,曾少颖,袁越,郭保静,韩波,沈捷,吴琳,张宴

DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2014.01.005

2014-01-01

Abstract:Objective To investigate the safety and efficacy of radiofrequency catheter ablation(RFCA) for different kinds of pediatric tachyarrhythmias.Methods Clinical materials (April 26,1994-September 30,2012)included 3 058 pediatric patients [(7.6±3.8) years old] who received intra-cardiac electrophysiological (EP) study and RFCA for tachyarrhythmia from 8 hospitals in China.The efficacy and recurrence rates for different age groups were compared.Results Totally 3 058 patients received EP study including 2 561(83.7％) cases of supraventricular tachycardia(SVT) and 497(16.3％) cases of ventricular tachycardia/premature ventricular contraction(VT/PVC).SVT group includes 1 630 (63.6％) cases of atrioventricular reentrant tachycardia (AVRT),750 (29.3％) cases of atrioventricular nodular reentrant tachycardia (AVNRT),141 (5.5％) cases of focal atrial tachycardia(FAT) and 40 (1.6％)cases of atrial flutter/incisional reentrant atrial tachycardia (AF/ IRAT).RFCAs were performed on 2 958 cases of patients,success rate for the first procedure was 96.8％,recurrence rate was 4.8％ (primary ablated accessory pathway/origin 3.6％,new accessory pathway/origin/tachycardia type 1.2％).One thousand five hundreds and eighty cases of AVRT were ablated with success rate 97.7％,recurrence rate 4.0％ (primary ablated accessory pathway 2.4％,new accessory pathway 1.6％).Seven hundred and forty cases of AVNRT were ablated with success rate 99.3％,recurrence rate 4.4％ (primary ablated site 2.4％).Forty cases of AF/IRAT were ablated with success rate 97.5％ with no recurrence.One hundred and thirty-one cases of FAT were ablated with success rate 84.7％.Success rate for two-dimensional mapping group was 81.0％,that for three-dimensional mapping combined with cooled saline irrigated tip ablation was 91.5％.Recurrence rate for FAT ablation was 12.6％ (primary origin 11.7％).Four hundreds and sixty-seven cases of VT/PVC were ablated with success rate 93.1％.Success rate for two-dimensional mapping group was 92.1％,that for three-dimensional mapping combined with cooled saline irrigated tip ablation was 100％.VT/PVC originating from left mid-posterior ventricular septum had the highest success rate 96.9％,the lowest was 66.7％ for VT/PVC of multiple origins.Recurrence rate for VT/PVC ablation was 6.4％ (primary origin 5.5％).There are no differences of success rates among different age groups.There are 17 (0.55％)cases of complications,including 4 cases of complete atrioventricular block(0.13％),6 cases of Ⅱ degree atrioventricular block(0.20％),1 case of hematopneumo thorax(0.03％),1 case of anesthetic accident (0.03％) and 5 cases of vascular complication (0.16％).Conclusions RFCA can be effectively and safely applied to cure pediatric tachyarrhythmias with high success rate and low recurrence rate.RFCA can be the first choice therapy for some categories of pediatric tachyarrhythmias.The success rate,recurrence rate and complication rate for younger are no different from those older.While the procedure is technically more difficult so that selection of patients should be careful.Three dimensional mapping can significantly improve the success rate for complicated tachyarrhythmias.Experienced and sophisticated manipulations can help to avoid the occurrence of complications.
Arrhythmias in children undergoing orthotopic heart transplantation

Eser Doğan,Fırat Ergin,Mehmet B. Beyter,Gülçin K. Kaşıkçı,Şeyma Ş. Ön,Oğuzhan Ay,Reşit E. Levent,Çağatay Engin,Zülal Ülger

DOI: https://doi.org/10.3389/fcvm.2023.1323958

IF: 3.6

2024-01-12

Frontiers in Cardiovascular Medicine

Abstract:Introduction: Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Methods: We performed a retrospective clinical data review of all consecutive pediatric patients (aged 2–18 years) who underwent orthotopic HT for advanced heart failure at our institution between January 2007 and January 2023. Clinical, procedural, and follow-up data were collected and comprehensively analyzed. Results: We identified 27 children (66.7% males) with a median age of 15 years (IQR: 7–16) and a median weight of 45 kg (IQR: 22–66) at the time of the intervention. 24 patients (88.8%) were diagnosed with dilated cardiomyopathy, 2 (7.4%) with restrictive cardiomyopathy, and 1 (3.7%) with hypertrophic cardiomyopathy. On a median follow-up of 35.07 months (IQR: 13.13–111.87), arrhythmias were detected in 9 (33%) patients. Three patients developed symptomatic sinus node dysfunction at 18, 25, and 38 days and received permanent pacemakers. One patient developed a complete AV block during acute rejection at 76 months and received a temporary pacemaker. Two patients developed chronic sinus tachycardia at 4 and 16 months and were treated with Beta-blockers after eliminating all causes of sinus tachycardia. One patient developed a complete right bundle branch block at 12 months. One patient developed ventricular extrasystole at 10 months and was found to have grade 2 rejection. An Atrial extrasystole was detected in one patient at 96 months. We did not identify significant risk factors for arrhythmias post-HT. Discussion: After pediatric HT, early-onset rhythm disturbances, often attributed to surgery-related issues such as sinus node dysfunction, may necessitate invasive treatments like permanent pacemaker therapy. Close monitoring post-transplantation is crucial, and routine follow-up with Holter ECG is necessary to identify potential rhythm disorders even in the absence of symptoms. Rhythm disturbances that develop during follow-up can serve as early indicators of graft rejection and should be carefully evaluated.

cardiac & cardiovascular systems
Effect of radiofrequency catheter ablation for different types of tachyarrhythmias in 1000 children

Xiao-mei LI,Yan ZHANG,Hai-ju LIU,Yan-hui LI,Min BAO

DOI: https://doi.org/10.3760/j.issn.2095-428X.2013.06.007

2013-01-01

Abstract:Objective To investigate the success rate,factors associated with recurrence,safety and effect of age on results of radiofrequency catheter ablation(RFCA) for different types of tachyarrhythmias in children.Methods A thousand children diagnosed as tachyarrhythmias underwent electrophysiological study (EPS),with mean age (7.6 ±3.8) years old(0.33-16.50 years old).RFCA methods and results for different kinds of tachyarrhythmias along with recurrence and complications were analyzed.RFCA results for different age groups were compared.Results A thousand children underwent EPS.The number of atrioventricular reentrant tachycardia(AVRT) was 560 (56％),atrioventricular nodal reentrant tachycardia (AVNRT) was 210 (21％),ventricular tachycardia/ventricular premature contraction (VT/PVC) was 159 (15.9％),focal atrial tachycardia (FAT) was 49 (4.9％),and atrial flutter/incisional reentrant atrial tachycardia (AF/IRAT) was 22 (2.2％).Totally 958 children underwent RFCA,among whom success rate was 96.2％ and recurrence rate was 8.1％.EPS performed on recurred cases showed restoration of primary pathway/origin was 5.3％,while appearance of new pathway/origin was 2.8％.Five hundred and thirty-three AVRT cases underwent RFCA,among whom success rate was 98.0％,recurrence rate was 8.4％,restoration of primary pathway was 4.0％,and appearance of new pathway was 4.4％.Success rate of right anterior/mid septal pathway was relatively low (85.3 ％),but its rate of restoration of primary pathway was high (31.0％),as 205 cases of AVNRT underwent RFCA,among whom success rate was 100％,recurrence rate was 5.9％,and restoration of primary origin was 4.9％,while 22 cases of AF/IRAT underwent RFCA,among whom success rate was 95.5％ with no recurrence,46 cases of FAT underwent RFCA,in which success rate was 84.8％ ; success rates for two-dimensional mapping group and three-dimensional mapping combined with cool-tip ablation group were 62.5％ and 96.7％ respectively and the difference was significant (P ＜ 0.05),as 10 cases recurred in which 7 originated from atrial appendages,and these 7 cases were successfully cured by appendectomy,152 cases of VT/PVC underwent RFCA,in which success rate was 89.5％,recurrence rate was 6.6％,restoration of primary origin was 5.9％.There was no difference in success rate between different age groups.The gross success rates and success rates for different types of arrhythmias between early and late periods were not different,while recurrence rates for AVNRT and left anterior pathways in early periods were significantly higher than late periods(P ＜0.05).There were totally 8 cases with complications(0.84％),including 2 cases of complete atrioventricular block and 1 case of anesthetic accident which happened in early period.The other 5 were vascular complications,and there was no death.Conclusions RFCA can be safely used as frontline treatment to cure some kinds of tachyarrhythmias in children with high success rate and low recurrence rate.There is no difference in rates of success,recurrence and complication between younger and older children,while difficulty for procedure increased for the former so that caution should be made for selection of patients.Application of three-dimensional mapping for difficult arrhythmias can increase success rate for ablation.Proficient experience and skillful manipulation are the main factors to avoid complications.
Diagnosis and treatment of neonatal arrhythmia

YE Hong-mao

DOI: https://doi.org/10.3969/j.issn.1672-6170.2009.06.005

2009-01-01

Abstract:Neonatal arrhythmia is an abnormal cardiac rhythm which is different from normal heart beat rhythm due to changes of autorhythmicity,excitability and conductibility of cardiac muscle.It includes abnormalities of frequency,rhythm,heart beat location and electric activity order.This article explain etiopathogenisis of common neonatal arrhythmia,clinical manifestation,ECG characteristic and progress of diagnosis and therapy.
Radiofrequency catheter ablation of atrial tachycardia in children without structural heart disease

ZHOU Jing,DING Yansheng,YANG Junjuan

DOI: https://doi.org/10.3969/j.issn.1004-8812.2009.03.003

IF: 37.8

2010-01-01

Circulation

Abstract:Objective To investigate electrophysiologic characteristics,the original site of atrial tachycardia(AT)and the results of radiofrequency catheter ablation(RFCA)in children without structural heart disease.Methods Electrophysiologic study and RFCA were performed in 46 children with AT.The site of origin of AT was mapped by using activation mapping during tachycardia.Magnetic electroanatomical mapping(CARTO system)for ablation of atrial tachycardia was performed in 4 patients.Preselecting a temperature of 50~60 ℃ was selected for ablation.Results Electrophysiologic study verified that the mechanism of all the tachycardias in 46 children was focal AT,which might be short paroxysmal,paroxysmal or persistent.1 child also had atrioventricular nodal reentrant tachycardia.ATs were successfully ablated in 41 children(89%),in which 39 had one original site(27 foci in right atrium and 12 foci in left atrium),2 had at least two original sites.Conclusion The success rate of RFCA in ATs of children without structural heart disease was relatively high.Atrial taclycardia could be eliminated by radiofrequency current with safety and efficacy.
Strengthen the understanding of arrhythmia-induced cardiomyopathy in children

Qingyou Zhang,Junbao Du

DOI: https://doi.org/10.3760/cma.j.issn.2095-428X.2017.01.001

2017-01-01

Abstract:Arrhythmia-induced cardiomyopathy (AIC) is a myocardial disease condition in which left ventricular dysfunction and cardiomegaly are induced or mediated by atrial or ventricular arrhythmias.The pathophysiological mechanisms remain unclear.Early recognition of AIC and provision of prompt treatment with pharmacological or ablative techniques could result in symptom resolution and recovery of ventricular function.But,the long-term prognosis of these patients is not clear and needs further observation and research.

[TREATMENT OF CARDIAC ARRHYTHMIAS IN CHILDHOOD].

Radiofrequency Catheter Ablation For Treatment Of Paroxysmal Supraventricular Tachycardia In Children

An adaptive clinical test of temporal resolution: Age effects

Cardiac Ablation in the Pediatric Population at a Tertiary Care Center in a Developing Country

Tachyarrhythmias in congenital heart disease

Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts

Radiofrequency catheter ablation therapy used in 123 children with drug - refractory tachycardia arrhythmias

[Abnormalities syndrome in partial trisomy of the chromosome 13].

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management

Efficacy and Safety of Radiofrequency Catheter Ablation of Tachyarrhythmias in 123 Children under 3 Years of Age.

Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies

The essentials of mental nursing.

Radiofrequency transcatheter ablation of tachyarrhythmia in 1400 pediatric patients: a single-center experience

Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association

Pediatric intra-cardiac electrophysiological study and radiofrequency catheter ablation of tachyarrhythmia——a national multicenter clinical study

Arrhythmias in children undergoing orthotopic heart transplantation

Effect of radiofrequency catheter ablation for different types of tachyarrhythmias in 1000 children

Diagnosis and treatment of neonatal arrhythmia

Radiofrequency catheter ablation of atrial tachycardia in children without structural heart disease

Strengthen the understanding of arrhythmia-induced cardiomyopathy in children